https://www.facebook.com/103435188296683/

NoeticInsight

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from NoeticInsight, Medical and health, 1 Cattano Avenue, Morristown, NJ.

03/16/2026

👉The Mayo Clinic has shared some of their greatest strides from 2025, including “virtual clinical trials” that combine advanced computer modeling with real patient data, the discovery of a new biomarker in brain tumors, new standards of care to find breast cancer in women with dense breast tissue, and more.

⭐Are you prepared to take immediate action in the rapidly evolving healthcare industry? Connect with NoeticInsight to see new possibilities: https://hubs.li/Q046n8g_0

Read more at: https://hubs.li/Q046n1JL0

03/13/2026

📈In the clinical trial, pembrolizumab reduced the risk of disease progression or death by 28% and reduced the risk of death by 24% compared with placebo plus paclitaxel with or without bevacizumab.

⭐Want unbiased insights on what this data might mean? Get started with NoeticInsight: https://hubs.li/Q046ngR_0

Source: https://hubs.li/Q046nmsN0

03/11/2026

👉A PRIMO Summit sponsor is passionate about learning and development for oncology practitioners and the integration of immuno and molecular therapies into practices.

🗨️Sound like you? Learn more about sponsoring one of our upcoming Summits:

- Gynecologic Cancers: May 2026, Houston, TX
- Breast Cancer: June 2026, Washington, D.C.
- Leukemia/Lymphomas: July 2026, Boston, MA

✨Learn more at https://hubs.li/Q046mkvW0 or find a list of our other Summits at https://hubs.li/Q046mBr30

03/06/2026

💭Imagine your brand here...

PRIMO Hawaii convenes oncology leaders, KOL faculty, and practicing clinicians for meaningful clinical dialogue and networking.

A limited number of sponsorship placements remain for the PRIMO Annual Meeting. If your team is considering participating, now is the time to secure your spot.

👉 Explore sponsorship opportunities https://hubs.li/Q045PjF80

02/25/2026

🔎What does your watchlist include for 2026 FDA approvals? New treatment approvals may include a different type of narcolepsy medicine, an oral option for a high-cholesterol treatment that’s currently available as an injection, and a one-time gene therapy for the extremely rare Hunter syndrome.

👉With new approvals come new shake-ups in prescribing patterns and access for patients. Feel prepared by getting an expert opinion: https://hubs.li/Q0432zys0

Source: https://hubs.li/Q0432BxN0

02/24/2026

📍We’ll be at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting! Connect with us to learn more about how NoeticInsight can power your congress experience, even after the data has been presented.

https://hubs.li/Q0432KWW0

02/19/2026

👉PRIMO brings together leading oncologists and cancer care professionals to share the latest advancements in cancer treatment and clinical decision-making. What’s more, the Women in Science award will honor a leader who has demonstrated exceptional dedication, passion, and impact in the fight against cancer.

Check out more about PRIMO: https://hubs.li/Q0432MZk0

02/17/2026

🔎It can be challenging to keep up with the data details for every drug approval. That’s where NoeticInsight steps in.

📈In a rapidly evolving healthcare industry, we know how crucial it is to quickly and easily access health data insights to make informed decisions. That’s why we’ve curated a suite of targeted tools to help: https://hubs.li/Q0427GyP0

Source: https://hubs.li/Q0427GZ90

02/12/2026

👉More than 850 abstracts will be presented at the ASCO Genitourinary Cancers Symposium.

Sound like a lot of data? It is! Having a strategic edge to turn information into practical applications can be your gamechanger.

📍Connect with us at https://hubs.li/Q0427C_S0

02/09/2026

💊6 new treatments were approved in December 2025. Did you catch them all? More importantly, do you know what their anticipated effect will be on their respective treatment landscapes? Get an expert opinion on these approvals with NoeticInsight:

- Jaypirca for adult relapsed/ refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

- Breyanzi for adult relapsed/refractory marginal zone lymphoma

- Rybrevant Faspro for epidermal growth factor receptor-mutated non-small cell lung cancer

- Rubraca for adult deleterious BRCA-mutated metastatic castration-resistant prostate cancer

- Lunsumio VELO for adult relapsed/refractory follicular lymphoma

Get started at https://hubs.li/Q0427CMF0

Source: https://hubs.li/Q0427D-90

01/29/2026

🗨️FDA to lower the number of trails trials required for approval of drugs What will it mean for the FDA to lower the number of trials necessary for drug approval? The move may not be that surprising, given that drugmakers already submit only one pivotal trial for approval.

🔎Looking for an expert’s insight into the latest news in pharma and the life sciences? NoeticInsight provides tailored insights, in real-time, from your global clinical experts. See how at https://hubs.li/Q0409b670

Source: https://hubs.li/Q0409f_q0

$⚕️Anito-cel is an experimental CAR T cell therapy for relapsed/refractory multiple myeloma patients that demonstrated 97...$

01/27/2026

⚕️Anito-cel is an experimental CAR T cell therapy for relapsed/refractory multiple myeloma patients that demonstrated 97% overall response rate and 68% complete response rate. The therapy will undergo Phase 3 study to compare against the current standard of care.

📌Interested in how this trial data is shaping the market? Talk to an expert rapidly through a secure platform with NoeticInsight: https://hubs.li/Q0408T0j0

Source: https://hubs.li/Q0408SKV0

Address

1 Cattano Avenue
Morristown, NJ
07960

Website

facebook.com

Alerts

Be the first to know and let us send you an email when NoeticInsight posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Morristown?